San Antonio Business Journal (July 13, 2016) One of San Antonio’s more promising bioscience companies, bioAffinity Technologies Inc., has locked up a key deal.
read moreSAN ANTONIO, TX (July 13, 2016) bioAffinity Technologies today announced the renewal of its collaborative agreement with The University of Texas Health Science Center at San Antonio for research and development of novel cancer diagnostic and therapeutic agents.
read more
San Antonio Business Journal (July 8, 2016)
San Antonio’s bioAffinity Technologies Inc. has hired a senior executive with strong ties to the city’s bioscience industry to help lead its new subsidiary — OncoSelect Therapeutics LLC.
SAN ANTONIO, TX (July 7, 2016 ) bioAffinity Technologies today announced that William Bauta, Ph.D., will join the company in September 2016 as Senior Vice President for Research and Development, Therapeutics.
read moreSAN ANTONIO, TX (June 23, 2016) bioAffinity Technologies today announced the formation of OncoSelect Therapeutics, LLC, a subsidiary company that will leverage bioAffinity’s proprietary porphyrin-based diagnostic technology to target a variety of cancers for precision treatment.
read more
bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.